PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria

Dermatology

Volumn 224, Issue 4, 2012, Pages 340-345

  Brzoza, Z ^a   Grzeszczak, W ^a   Rogala, B ^a   Trautsolt, W ^a   Moczulski, D ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chronic urticaria; Polymorphism; PTPN22

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 22; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CHRONIC URTICARIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PREVALENCE; PRIORITY JOURNAL; PTPN22 GENE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TEST; URTICARIA ACTIVITY SCORE;

ADULT; AUTOIMMUNITY; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; URTICARIA; YOUNG ADULT;

EID: 84864869570     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000339332     Document Type: Article

References (44)

1. Brzoza Z, Kasperska-Zajac A, Badura-Brzo-za K, Matysiakiewicz J, Hese RT, Rogala B: Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress. Psychosom Med 2008; 70:723-728.
2. Kaplan AP: Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114:465-474.
3. Brzoza Z, Kasperska-Zajac A, Rogala B: Serum prolactin concentration and its relationship with dehydroepiandrosterone sul-fate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test. Allergy 2007; 62: 566-567.
4. Kasperska-Zajac A, Brzoza Z, Rogala B: Lower serum concentration of dehydroepi-androsterone sulphate in patients suffering from chronic idiopathic urticaria. Allergy 2006; 61:1489-1490.
5. Sabroe RA, Fiebiger E, Francis DM, et al: Classification of anty-Fcepsilon and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002; 110:492-499.
6. Konstantinou GN, Asero R, Maurer M, Sa-broe RA, Schmid-Grendelmeier P, Grattan CE: EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64:1256-1268.
7. O'Donnell BF, O'Neill CM, Francis DM, et al: Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 853-858.
8. Levy Y, Segal N, Weintrob N, Danon YL: Chronic urticaria: association with thyroid autoimmunity. Arch Dis Child 2003; 88:517-519.
9. Leznoff A, Josse RG, Denburgh J, Dolovich J: Association of chronic urticaria and angio-edema with thyroid autoimmunity. Arch Dermatol 1983; 119:636-640.
10. Lanigan SW, Short P, Moult P: The association of chronic urticaria and thyroid autoim-munity. Clin Exp Dermatol 1987; 12:335-338.
11. Leznoff A, Sussman GL: Syndrome of idio-pathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66-71.
12. Henderson CA, Highet AS: Urticaria associated with thyrotoxicosis. Clin Exp Dermatol 1995; 20:173-174.
13. Turktas I, Gokcora N, Demirsoy S, Cakir N, Onal E: The association of chronic urticaria and angioedema with autoimmune thyroid-itis. Int J Dermatol 1997; 36: 187-190.
14. Kikuchi Y, Fann T, Kaplan AP: Antithyroid antibodies in chronic urticaria and angioede-ma. J Allergy Clin Immunol 2003; 112:218.
15. Asero R, Lorini M, Tedeschi A: Association of chronic urticaria with thyroid autoimmu-nity and Raynaud phenomenon with anti-centromere antibodies. J Allergy Clin Immunol 2003; 111:1129-1130.
16. Ryhal B, DeMera RS, Shoenfeld Y, Peter JB, Gershwin ME: Are autoantibodies present in patients with subacute and chronic urticaria? J Investig Allergol Clin Immunol 2001; 11: 16-20.
17. Grattan CEH, D'Cruz DP, Francis DM, Whiston C, Hughes GRV, Greaves MW: An-tiendothelial cell antibodies in chronic urticaria. Clin Exp Rheumatol 1995; 13: 272-273.
18. Baranzini S: The genetics of autoimmune diseases: a networked perspective. Curr Opin Immunol 2009; 21: 596-605.
19. Hewagama A, Richardson B: The genetics and epigenetics of autoimmune diseases. J Autoimmunity 2009; 33:3-11.
20. Cloutier JF, Veillette A: Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and phosphatase. J Exp Med 1999; 189: 111-121.
21. Gjorloff-Wingren A, Saxen AM, Williams S, Hammi D, Mustelin T: Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein ty-rosine phosphatase PEP. Eur J Immunol 1999; 29:3845-3854.
22. Begovich AB, Carlton VE, Honigberg A, et al: Amissense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337.
23. Bottini N, Musumeci L, Alonso A, et al: A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet 2004; 36:337-338.
24. Kyogoku C, Langfeld CD, Ortmann WA, et al: Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75: 504-507.
25. VelagAmR, Wilson V, Jennings CE, et al: The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is Amajor determinant of Graves' disease. J Clin Endo-crinol Metab 2004; 89: 5862-5865.
26. Criswell LA, Pfeiffer KA, Lum RF, et al: Analysis of families in the multiple au toimmune disease genetics consortium (MADGC) collection: the PTPN22620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76: 561-571.
27. Brzoza Z, Grzeszczak W, Trautsolt W, Mo-czulski D: Protein tyrosine phosphatase-22 (PTPN-22) polymorphism in the pathogen-esis of chronic urticaria. Allergy 2011; 66: 1392-1393.
28. Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gre-gersen PK, Beasley E, Thomson G, Amos CI, Begovich AB: PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005; 77: 567-581.
29. Chung SA, Criswell LA: PTPN22: its role in SLE and autoimmunity. Autoimmunity 2007; 40:582-590.
30. Kawasaki E, Awata T, Ikegami H, et al: Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phospha-tase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 2006; 140: 586-593.
31. Huang JJ, Qiu YR, Li HX, Sun DH, Yang J, Yang CL: A PTPN22 promoter polymorphism-1123G>C is associated with RA pathogenesis in Chinese. Rheumatol Int 2012; 32:767-771.
32. Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M: How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63:777-780.
33. Zuberbier T, Asero R, Bindslev-Jensen C, et al: EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64:1417-1426.
34. Fiebiger E, Hammerschmid F, Stingl G, Maurer D: Anti-FcRIα autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship. J Clin Invest 1998; 101:243-251.
35. Marone G, Spadaro G, Palumbo C, Con-dorelli G: The anti-IgE/anti- FcepsilonRI-alpha autoantibody network in allergic and autoimmune diseases. Clin Exp Allergy 1999; 29:17-27.
36. Gruber BL, Kaufman LD, Marchese MJ, Roth W, Kaplan AP: Anti-IgE autoantibod-ies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum 1988; 31: 1000-1006.
37. Tomer Y, Davies TF: Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24:694-717.
38. Ban Y, Tomer Y: Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol 2005; 12:47-58.
39. Simmonds MJ, Gough SC: Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Exp Immunol 2004; 136: 1-10.
40. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF: Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003; 73: 736-747.
41. Majorczyk E, Jasek M, Płoski R, et al: Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma. Eur J Hum Genet 2007; 15:1043-1048.
42. IchimurAm, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y: Associations of protein tyro-sine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Grave's disease in a Japanese population. Thyroid 2008; 18: 625-630.
43. Onengut-Gumuscu S, Buckner JH, Concan-non P: A haplotype-based analysis of the PTPN22 locus in type 1 diabetes. Diabetes 2006; 55:2883-2889.
44. Cinek O, Hradsky O, Ahmedov G, Slavcev A, Kolouskova S, Kulich M, Sumnik Z: Noinde-pendent role of the-1123 G1C and +2740 A1G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res Clin Pract 2007; 76:297-303.